Holly D. Bennett

Internal Medicine

314 Chris Gaupp Dr Ste 101
Galloway, NJ 08205

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.

Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.

Journal: PloS one

Published: November 02, 2012

Showing 1-1 of 1

Last Updated: 09/26/2026